Literature DB >> 8465126

The use of ex vivo-activated memory T cells (autolymphocyte therapy) in the treatment of metastatic renal cell carcinoma: final results from a randomized, controlled, multisite study.

S Graham1, R K Babayan, D L Lamm, I Sawczuk, S D Ross, P T Lavin, M E Osband, R J Krane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8465126

Source DB:  PubMed          Journal:  Semin Urol        ISSN： 0730-9147


× No keyword cloud information.
  4 in total

1.  High incidence of asymptomatic brain lesions in metastatic renal cell carcinoma.

Authors:  E K Seaman; S Ross; I S Sawczuk
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 2.  Harnessing the PD-1 pathway in renal cell carcinoma: current evidence and future directions.

Authors:  Abhishek Tripathi; Charles G Drake; Lauren C Harshman
Journal:  BioDrugs       Date:  2014-12       Impact factor: 5.807

3.  Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.

Authors:  R Houston Thompson; Michael D Gillett; John C Cheville; Christine M Lohse; Haidong Dong; W Scott Webster; Kent G Krejci; John R Lobo; Shomik Sengupta; Lieping Chen; Horst Zincke; Michael L Blute; Scott E Strome; Bradley C Leibovich; Eugene D Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

Review 4.  Adoptive T cell therapy for cancer in the clinic.

Authors:  Carl H June
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.